# Rexulti

NDC: 59148-040
Generic name: brexpiprazole
Labeler / Manufacturer: Otsuka America Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20150710

FDA application: NDA205422

## Active ingredients

- BREXPIPRAZOLE: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59148-040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59148-040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d301358-6291-4ec1-bd87-37b4ad9bd850